CAROL J. ROLLINS, Pharm.D., M.S., RD, BCNSP, FASHP (firstname.lastname@example.org) is Clinical Professor at the University of Arizona, College of Pharmacy, Tucson, and partner in Rollins Associates. As Coordinator of the parenteral nutrition team at the university-associated medical center, she covered inpatient and home care patients from neonatal to geriatrics for over 30 years, directed a PGY2 nutrition support pharmacy residency, and served as preceptor to the PGY1 and multiple PGY2 residency programs. She earned her B.S. Pharmacy and Pharm.D. from the University of Arizona. Carol completed a nutrition support pharmacy practice residency at University Medical Center, Tucson, Arizona. Her M.S. in Food Science and Nutrition is from Purdue University.
Service to the Section of Clinical Specialists and Scientists includes four years as Director-at-Large, Section representative on the Continuity of Care Taskforce, inaugural Chair and three years as a member of the Section Advisory Group (SAG) on Preceptor Development, SAG on Clinical Leadership, and as a network facilitator. She has been a member of the Section from its first year. Other ASHP activities include work on accreditation site reviews, and development of initial and updated educational outcomes, goals and objectives for nutrition support pharmacy residencies; participation in planning/development of the interdisciplinary Nutrition Support Certificate; multiple activities with the Section of Ambulatory Care Practitioners (initially the Home Care Section); SAG on Home Infusion and Educational Steering Committee. Carol has served in the ASHP House of Delegates as a delegate for 10 years and as an alternate delegate for three years. She speaks regularly at ASHP meetings and webinars on the subjects of preceptor development, transitioning/continuity of care, and nutrition support.
When a patient says, “What am I supposed to do, die because I don’t fit the protocol?” it is clear that pharmacy specialist/scientists’ expertise is needed to augment current protocols, think outside the [protocol] box, and contribute to exploration of alternate therapies. Reviewing important information with a patient/care-provider only to hear, “We’ve seen more than a dozen [healthcare professionals, including non-specialist pharmacists], you are the first to mention this,” reinforces that pharmacy specialist/scientists are critical to optimal patient outcomes. We must utilize opportunities to collaborate with other ASHP sections on education and projects to assure optimal care of patients who can benefit from the knowledge and skills of pharmacy specialist/scientists, irrespective of their site of care or the location in which healthcare is provided. With current healthcare systems encompassing facilities in rural as well as urban and suburban locations and expanding telecommunications capabilities, there are opportunities to improve access to the expertise of pharmacy specialist/scientists in all sites while improving continuity of care through collaboration regardless of where the healthcare is provided. We must also continue our journey toward recognition as pharmacist providers; this has been a demanding journey with many worthy interruptions and detours slowing achievement of our ultimate goal. It requires a continued focus so that pharmacists can provide patient care with equitable compensation.
I am honored to be nominated for the position of Chair for the Section of Clinical Specialists and Scientists and look forward to continuing to serve members of the Section.